Scarless Advanced Breast Extended Oncoplasty: The ScarABEO Study

Launched by ISTITUTO ONCOLOGICO VENETO IRCCS · Mar 25, 2025

Keywords

ClinConnect Summary

The ScarABEO Study is a clinical trial focusing on a new surgical technique for women with early-stage breast cancer. This technique, called oncoplastic breast conserving surgery (OBCS) using chest wall perforator flaps (CWPFs), aims to remove tumors while also preserving the appearance of the breast. The study is looking to gather information on how well this method works in terms of both cancer control and cosmetic results. It may be especially helpful for women who have certain challenges with their breast size or tumor placement that make traditional surgeries less effective.

To participate in the study, women must be 18 years or older and have had surgery for early-stage breast cancer within the last ten years, using the CWPF technique. Participants will be monitored for at least a year to see how they recover and how well the surgery works. This research is important because it could help improve surgical options for breast cancer patients, leading to better outcomes and higher satisfaction with their results.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • Patients treated with BCS combined with CWPFs for primary stage I-III invasive cancer (IC) or ductal carcinoma in situ (DCIS);
• • Patients treated during the last 10 years (2015-2025);
• • Patients aged 18 years or more;
• • Cases with at least one-year follow-up.
• Exclusion Criteria:
• • Male Patients;
• • Patients aged less than 18 years;
• • Patients who underwent traditional breast conserving surgery or OBCS with displacement techniques;
• • Patients who underwent mastectomy;
• • Patients who underwent implant-based reconstruction;
• • Patients with unresectable breast cancer or metastatic disease;
• • Patients who were lost during follow-up.